GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy https://www.biorxiv.org/content/10.1101/2023.04.13.536748v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.